Jiangsu Sihuan Bioengineering Co., Ltd.四环生物
Venture Capital2 recorded investments
Jiangsu Sihuan Bioengineering is the Shenzhen-listed company with stock code 000518. In September 2026 it announced a proposed RMB160 million acquisition of 65.6146% of Zhongrun Pharmaceutical.
Recorded Investments
- RaisedFunding amount requires an account.